Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the safety of 2 dosage regimens of Intravenous (IV)
iron Ferric Carboxymaltose (FCM) in comparison to placebo in patients with Restless Legs
Syndrome (RLS)